2017 to 2023 Saw Decrease in Primary Care Visit Rates, Access in Older Adults

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

THURSDAY, May 7, 2026 -- Across Medicare beneficiaries, primary care visit rates and access decreased from 2017 to 2023, and telemedicine accounted for a small proportion of visits, according to a study published online May 1 in JAMA Health Forum.

Ishani Ganguli, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues quantified trends in primary care use and examined the role of telemedicine in primary care access in a serial cross-sectional study using 2017 to 2023 100 percent claims and administrative data for traditional Medicare beneficiaries.

The researchers observed a decrease in primary care visit rates among 258,324,127 person-years from 2017 to 2023, from 2.54 to 2.27 per person-year; access declined from 61.9 to 59.8 percent. Virtual visits comprised 7 percent of primary care visits in 2023, and 14 percent of beneficiaries who accessed primary care did so using telemedicine. From 2019 to 2023, there was a slight increase in disparities in access by race, geography, and income; beneficiaries in historically underserved groups based on race, geography, and income who accessed primary care were more likely to use telemedicine to do so. From 2019 to 2023, there was a decrease in primary care continuity from 0.72 to 0.65; in 2023, continuity was slightly higher for those using telemedicine for primary care.

"These results likely reflect dynamic shifts in primary care workforce and practice patterns, with important implications for Medicare telemedicine reimbursement and primary care payment reform," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-05-08 09:38

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords